BioWorld

April 7, 2008

Avant Gets $11.5M Payday with FDA OK of Rotarix

Avant Immunotherapeutics Inc. will see an additional $11.5 million in milestone payments for the rotavirus vaccine Rotarix, now that it has been FDA-approved. (BioWorld Today) Read More

Deerfield Deal Secures $30M for Vivus' Avanafil Phase III Trials

Mitochondrial DNA Plays Role in Predilection to Metastasize

House OKs $50B HIV Bill, Senators Gearing for a Fight

Abraxis Buys 2 Companies, Gets Cyclodextrin Platform

Other News To Note

Clinic Roundup

Today's news in brief

BioWorld

BioWorld briefs for Jan 30, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Jan. 30, 2026.

Brain-derived tau in blood predicts stroke severity and outcome

BioWorld Science

Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...

Centessa’s CNT-9982 shows promise for MDD

BioWorld Science

Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...

First-in-class ADC targeting DEM-TXX shows high preclinical efficacy

BioWorld Science

Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...